FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and is applicable for treating diseases and disorders by introducing a composition containing a neurotoxic component of the toxin complex Clostridium botulinum. The composition is free from any other protein of the toxin complex Clostridium botulinum The composition is introduced in short intervals and/or in large doses.
EFFECT: group of inventions allows increasing doses and rate of treatment not causing formation of neutralised antibodies to the neurotoxic component.
18 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PROCESS FOR PREPARING HIGHLY PURE NEUROTOXIC COMPONENT OF BOTULINUM TOXIN AND USES THEREOF | 2014 |
|
RU2663136C2 |
| CLOSTRIDIAL NEUROTOXINS WITH MODIFIED PERSISTENCE | 2009 |
|
RU2524429C2 |
| COMPLEX, AGENT AND APPLICATION OF TYPE A BOTULINUM TOXIN CLOSTRIDIUM BOTULINUM | 2020 |
|
RU2783511C1 |
| CONTAINER PRE-FILLED WITH BOTULINUM TOXIN | 2015 |
|
RU2694820C2 |
| CONTAINER PRE-FILLED WITH BOTULINUM TOXIN | 2015 |
|
RU2722290C2 |
| BOTULINUM TOXIN FOR USE IN TREATING PARATONIA | 2015 |
|
RU2700939C2 |
| STABILIZED NON-PROTEIN COMPOSITIONS OF CLOSTRIDIAL TOXIN | 2017 |
|
RU2762607C2 |
| METHOD FOR BOTULINUM TOXIN PRODUCTION | 2014 |
|
RU2627159C2 |
| METHODS OF TREATING CHRONIC NEUROGENIC INFLAMMATION BY MODIFIED CLOSTRIDIAL TOXIN | 2010 |
|
RU2568844C2 |
| IMPROVED USE OF BOTULINUM NEUROTOXIN IN THE TREATMENT OF SIALORRHEA | 2018 |
|
RU2778481C2 |
